NAV

Butyl alcohol

Identification

Generic Name
Butyl alcohol
DrugBank Accession Number
DB02145
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 74.1216
Monoisotopic: 74.073164942
Chemical Formula
C4H10O
Synonyms
  • 1-butanol
  • Butan-1-ol
  • Butanol
  • N-butanol
  • N-butyl alcohol
External IDs
  • FEMA NO. 2178
  • NSC-62782
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UHaloalkane dehalogenaseNot AvailablePseudomonas paucimobilis
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as primary alcohols. These are compounds comprising the primary alcohol functional group, with the general structure RCOH (R=alkyl, aryl).
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Alcohols and polyols
Direct Parent
Primary alcohols
Alternative Parents
Hydrocarbon derivatives
Substituents
Aliphatic acyclic compound / Hydrocarbon derivative / Primary alcohol
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
primary alcohol, alkyl alcohol (CHEBI:28885) / Fatty alcohols (LMFA05000109) / a primary alcohol (BUTANOL)
Affected organisms
Not Available

Chemical Identifiers

UNII
8PJ61P6TS3
CAS number
71-36-3
InChI Key
LRHPLDYGYMQRHN-UHFFFAOYSA-N
InChI
InChI=1S/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H3
IUPAC Name
butan-1-ol
SMILES
CCCCO

References

Synthesis Reference

Howard H. Chou, Jay D. Keasling, "Host Cells and Methods for Producing 3-Methyl-2-buten-1-ol, 3-Methyl-3-buten-1-ol, and 3-Methyl-butan-1-ol." U.S. Patent US20100205855, issued August 19, 2010.

US20100205855
General References
Not Available
Human Metabolome Database
HMDB0004327
KEGG Drug
D03200
KEGG Compound
C06142
PubChem Compound
263
PubChem Substance
46507086
ChemSpider
258
BindingDB
36173
RxNav
1310579
ChEBI
28885
ChEMBL
CHEMBL14245
ZINC
ZINC000001530354
PDBe Ligand
1BO
Wikipedia
Butanol
PDB Entries
1g4h / 1okx / 1ooh / 1yky / 2huf / 2huu / 2vdg / 3b6x / 3et2 / 3s3e …
show 20 more

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount
0CompletedBasic ScienceNeurodegenerative Disorders1
0RecruitingBasic ScienceCardiovascular Disease (CVD) / Healthy Subjects (HS)1
0RecruitingBasic ScienceCoronavirus Disease 2019 (COVID‑19) / Myofascial Pain Syndrome1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)-89.8 °CPhysProp
boiling point (°C)117.7 °CPhysProp
water solubility6.32E+004 mg/L (at 25 °C)TEWARI,YB ET AL. (1982)
logP0.88HANSCH,C ET AL. (1995)
pKa16.1 (at 25 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
Water Solubility158.0 mg/mLALOGPS
logP0.84ALOGPS
logP0.81Chemaxon
logS0.33ALOGPS
pKa (Strongest Acidic)16.95Chemaxon
pKa (Strongest Basic)-1.9Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area20.23 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity22.13 m3·mol-1Chemaxon
Polarizability9.21 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9975
Blood Brain Barrier+0.9671
Caco-2 permeable+0.7735
P-glycoprotein substrateNon-substrate0.6911
P-glycoprotein inhibitor INon-inhibitor0.9271
P-glycoprotein inhibitor IINon-inhibitor0.9763
Renal organic cation transporterNon-inhibitor0.9056
CYP450 2C9 substrateNon-substrate0.7943
CYP450 2D6 substrateNon-substrate0.8739
CYP450 3A4 substrateNon-substrate0.7518
CYP450 1A2 substrateNon-inhibitor0.5346
CYP450 2C9 inhibitorNon-inhibitor0.9197
CYP450 2D6 inhibitorNon-inhibitor0.9353
CYP450 2C19 inhibitorNon-inhibitor0.9112
CYP450 3A4 inhibitorNon-inhibitor0.9519
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9359
Ames testNon AMES toxic0.9323
CarcinogenicityNon-carcinogens0.5097
BiodegradationReady biodegradable0.9561
Rat acute toxicity1.6978 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.914
hERG inhibition (predictor II)Non-inhibitor0.9084
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-004l-9000000000-b70087d61cbf63d60bd5
GC-MS Spectrum - EI-BGC-MSsplash10-052f-9000000000-f8337e5e053a4d17e4ed
GC-MS Spectrum - EI-BGC-MSsplash10-052f-9000000000-610cf73e0b514e180dbd
GC-MS Spectrum - EI-BGC-MSsplash10-055f-9000000000-7e23cd40dde01cb89b6f
Mass Spectrum (Electron Ionization)MSsplash10-054o-9000000000-061591a78bc1cdeda799
MS/MS Spectrum - EI-B (HITACHI RMU-6M) , PositiveLC-MS/MSsplash10-052f-9000000000-69148177e3417cc669fd
MS/MS Spectrum - EI-B (HITACHI RMU-7M) , PositiveLC-MS/MSsplash10-052f-9000000000-7ebca2648ffd63942337
MS/MS Spectrum - EI-B (HITACHI M-80B) , PositiveLC-MS/MSsplash10-055f-9000000000-7e23cd40dde01cb89b6f
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-a8911dacdd6caf34a4ec
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-f034298d38e42126480b
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-5fa0031efe3623bfdf6b
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-384b9837b1fb08b867db
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-eb96ba773e23095fb825
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052f-9000000000-04fa9fcb32e389da3e8a
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-106.0281407
predicted
DarkChem Lite v0.1.0
[M-H]-106.0451407
predicted
DarkChem Lite v0.1.0
[M-H]-106.0840407
predicted
DarkChem Lite v0.1.0
[M-H]-122.78949
predicted
DeepCCS 1.0 (2019)
[M+H]+106.7156407
predicted
DarkChem Lite v0.1.0
[M+H]+106.6434407
predicted
DarkChem Lite v0.1.0
[M+H]+106.7358407
predicted
DarkChem Lite v0.1.0
[M+H]+124.68489
predicted
DeepCCS 1.0 (2019)
[M+Na]+106.0925407
predicted
DarkChem Lite v0.1.0
[M+Na]+106.0597407
predicted
DarkChem Lite v0.1.0
[M+Na]+106.0240407
predicted
DarkChem Lite v0.1.0
[M+Na]+132.88246
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Haloalkane dehalogenase
Kind
Protein
Organism
Pseudomonas paucimobilis
Pharmacological action
Unknown
General Function
Haloalkane dehalogenase activity
Specific Function
Catalyzes hydrolytic cleavage of carbon-halogen bonds in halogenated aliphatic compounds, leading to the formation of the corresponding primary alcohols, halide ions and protons. Has a broad substr...
Gene Name
linB
Uniprot ID
P51698
Uniprot Name
Haloalkane dehalogenase
Molecular Weight
33107.275 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at November 09, 2021 18:49